Advertisement

Sinus augmentation using human mesenchymal stem cells loaded into a β-tricalcium phosphate/hydroxyapatite scaffold

      Objective

      Implant placement in the posterior maxilla may often be contraindicated because of insufficient bone volume and presence of the maxillary sinus. In these situations, sinus floor augmentation frequently has been proposed as the best treatment. This clinical study was based on the hypothesis that the clinical effectiveness of adult mesenchymal stem cells (MSCs) loaded to the biphasic scaffold.

      Methods

      In this report, the clinical and radiographic results are presented on 6 consecutively treated patients using MSCs in combination with biphasic hydroxyl apatite/ β-tricalcium phosphate (HA/TCP) for sinus elevation. All the patients in the study had less than 3 mm initial bone height in the posterior maxillary area (IBH). MSCs were cultured and expanded from bone marrow aspirate for each patient. Three months after sinus elevation, radiographic evaluation was performed for the patients and the secondary bone height was measured (SBH1). In the second stage surgery, 30 implants were placed. Trephine bur was used as a pilot drill and a core biopsy was obtained from each implant site. Prosthetic rehabilitation of the patients was performed after 4 months. Secondary bone height was measured 9 months after implant placement (SBH2).

      Results

      Of 30 implants, 28 (93%) were considered clinically successful. Two implants were removed due to mobility at the time of surgical exposure. Histologic evaluation of the biopsy specimens revealed numerous areas of osteoid and bone formation HA/TCP, with no evidence of inflammatory cell infiltrate. Mean bone regenerate was 41.34%. Clinically, no complications were observed, and all implants were considered clinically osseointegrated after 4 months. Mean bone height was measured 3 and 12 months after sinus grafting (mean of SBH1= 12.08 mm and mean of SBH2= 10.08 mm).

      Conclusions

      These clinical and histological findings suggest that sinus grafting with HA/TCP in combination with MSCs provide a viable therapeutic alternative for implant placement. The findings suggest that the addition of MSCs to bone derivative/substitute materials may enhance bone formation in the maxillary sinus area. Of course more studies with the control groups are needed for the evaluation of this method as a clinical solution for the patients.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      References

        • Adell R.
        • Eriksson B.
        • Lekholm U.
        • Brånemark P.I.
        • Jemt T.
        A long-term follow-up study of osseointegrated implants in the treatment of totally edentulous jaws.
        Int J Oral Maxillofac Impl. 1990; 5: 347-359
        • Adell R.
        • Lekholm U.
        • Rockler B.
        • Brånemark P.I.
        A 15-year study of osseointegrated implants in treatment of the edentulous jaw.
        Int J of Oral Maxillofac Surg. 1981; 10: 387-416
        • Cox J.F.
        • Zarb G.A.
        The longitudinal clinical efficacy of osseointegrated dental implants:a 3- year report.
        Int J Oral Maxillofac Implants. 1987; 2: 91-100
        • Montazem A.
        • Valauri D.V.
        • St-Hilaire H.
        The mandibular symphysis as a donor site in maxillofacial bone grafting:A quantitative anatomic study.
        J Oral Maxillofac Surg. 2000; 58: 1368-1371
        • Boyne P.J.
        • James R.A.
        Grafting of the maxillary sinus floor with autogenous marrow and bone.
        J Oral Maxillofac Surg. 1980; 38: 613-616
        • Jensen S.S.
        • Broginni N.
        • Hansen H.E.
        • Schenk R.
        • Buser D.
        Bone healing and graft resorption of autograft, anorganic bovine bone and β- tricalcium phosphate.
        Clin Oral Implants Res. 2006; 17: 237-245
        • Al Ruhaimi K.A.
        Bone graft substitutes: a comperative qualitative histologic review of current osteoconductive grafting materials.
        Int J Oral Maxillofac Implants. 2001; 16: 105-114
        • Misch C.E.
        Density of bone: effect on treatment plans, surgical approach, healing, and progressive bone loading.
        Int J Oral Implantology. 1990; 6: 23-31
        • Benque E.
        • Zahedi S.
        • Brocard D.
        • Marin P.
        • Brunel G.
        • Elharar F.
        Tomodensitometric and histologic evaluation of the combined use of a collagen membrane and a hydroxyapatite spacer for guided bone regeneration: a clinical report.
        Int J Oral Maxillofac Implants. 1999; 14: 258-264
        • Friedenstein A.J.
        • Chailakhyan R.X.
        • Gerasimov U.V.
        Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diffusion chambers.
        Cell Tissue Kinetics. 1987; 20: 263-272
        • Pittenger M.F.
        • Mackay A.M.
        • Beck S.C.
        • Jaiswal R.K.
        • Douglas R.
        • Mosca J.D.
        • et al.
        Multilineage potential of adult human mesenchymal stem cells.
        Science. 1999; 284: 143-147
        • Kadiyala S.
        • Jaiswal N.
        • Bruder S.P.
        Culture-expanded, bone marrow-derived mesenchymal stem cells can regenerate a critical-sized segmental bone defect.
        Tissue Eng. 1997; 3: 173-185
        • Arinzeh T.L.
        • Peter S.
        • Archambault M.
        • van den Bos C.
        • Gordon S.
        • Krause K.
        • et al.
        Allogeneic mesenchymal stem cells regenerate bone in a critical-sized canine segmental defect.
        J Bone Joint Surg Am. 2003; 85-A: 1927-1935
        • Hirano S.
        • Shoji K.
        • Kojima H.
        • Omori K.
        Use of hydroxyapatite for reconstruction after surgical removal of intraosseous hemangioma in the zygomatic bone.
        Plast Reconstr Surg. 1997; 100: 86-90
        • Lieberman J.R.
        • Daluiski A.
        • Einhorn T.A.
        The role of growth factors in the repair of bone.
        J Bone Joint Surg Am. 2002; 84-A: 1032-1044
        • Cooper L.F.
        • Harris C.T.
        • Bruder S.P.
        • Kowalski R.
        • Kadiyala S.
        Incipient analysis of mesenchymal stem-cell-derived osteogenesis.
        J Dent Res. 2001; 80: 314-320
        • Dong J.
        • Kojima H.
        • Uemura T.
        • Kikuchi M.
        • Tateishi T.
        • Tanaka J.
        In vivo evaluation of a novel porous hydroxyapatite to sustain osteogenesis of transplanted bone marrow-derived osteoblastic cells.
        J Biomed Mater Res. 2001; 57: 208-216
        • Van der Bergh J.P.
        • Bruggenkate T.
        • Krekkeler G.
        • Tuinizing D.B.
        Sinus floor elevation and grafting with autogenous iliac crest bone.
        Clin Oral Implants Res. 1998; 9: 429-435
        • Trehyden H.
        • Jespen S.
        • Moller B.
        • Tucker M.M.
        • Rueger D.C.
        Sinus floor augmentation with simultaneous implant placement using a combination of deproteinized bone xenografts and recombinant human osteogenic protein-1.
        Clin Oral Implants Res. 1999; 10: 510-521
        • Van der Bergh J.P.
        • Bruggenkate T.
        • Krekkeler G.
        • Tuinizing D.B.
        Maxillary Sinus floor elevation and grafting with human demineralized freeze dried bone.
        Clin Oral Implants Res. 2000; 11: 487-493
        • Zijdeverlan S.A.
        • Zerbo I.R.
        • Bergh J.P.A.
        • Schulten E.A.
        • Bruggenkate C.M.
        Maxillary sinus Floor augmentation using β-TCP (cerasorb) alone compared to autogenous bone grafts.
        Int J Oral Maxillofac Implants. 2005; 20: 432-440
        • Schwartz Z.V.
        • Goldstein M.
        • Raviv E.
        • Hirsch A.
        • Ranly D.M.
        • Boyan B.D.
        Clinical evaluation of demineralised bone allograft in a hyaluronic acid carrier for sinus lift augmentation in humans: a computed tomography and histomorphometric study.
        Clin Oral Implants Res. 2007; 18: 204-211
        • Merkx M.A.W.
        • Maltha J.C.
        • Stolinga P.J.W.
        Assessment of the value of the organic bone additive in sinus floor augmentation: a review of clinical reports.
        Int J Oral Maxilofac Surg. 2003; 32: 1-6
        • Froum S.J.
        • Tarnow D.P.
        • Wallace S.S.
        • Rohrer M.D.
        • Cho S.
        Sinus floor elevation using anorganic bovine bone matrix (Osteograft/N) with and without autogenous bone: a clinical, histologic, radiographic, and histomorphometeric analysis.
        Int J Periodontics Restorative Dent. 1998; 18: 528-543